Analyst Price Target is $6.50
▲ +80.06% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for InnovAge in the last 3 months. The average price target is $6.50, with a high forecast of $7.00 and a low forecast of $6.00. The average price target represents a 80.06% upside from the last price of $3.61.
Current Consensus is
Hold
The current consensus among 2 investment analysts is to hold stock in InnovAge. This Hold consensus rating has held steady for over two years.
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.
Read More
